MA33440B1 - Nouvelles compositions - Google Patents
Nouvelles compositionsInfo
- Publication number
- MA33440B1 MA33440B1 MA34546A MA34546A MA33440B1 MA 33440 B1 MA33440 B1 MA 33440B1 MA 34546 A MA34546 A MA 34546A MA 34546 A MA34546 A MA 34546A MA 33440 B1 MA33440 B1 MA 33440B1
- Authority
- MA
- Morocco
- Prior art keywords
- papillomavirus
- proteins
- formulation
- new combinations
- constructs
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/01—DNA viruses
- C07K14/025—Papovaviridae, e.g. papillomavirus, polyomavirus, SV40, BK virus, JC virus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20023—Virus like particles [VLP]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Mycology (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Oncology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
La présente invention concerne de nouvelles constructions à base de protéines de papillomavirus, et leur utilisation dans la prévention de maladies à papillomavirus. Ces constructions sont des protéines chimériques à base de protéines L1 dans lesquelles est inséré un peptide L2 de papillomavirus. De telles protéines chimériques, qui se prêtent à la formulation de compositions immunogènes, en l'occurrence de compositions vaccinales, pourront éventuellement participer à la formulation de vaccins à base de pseudo-particules virales de type L1 de papillomavirus.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US22035809P | 2009-06-25 | 2009-06-25 | |
US23988009P | 2009-09-04 | 2009-09-04 | |
US32210210P | 2010-04-08 | 2010-04-08 | |
PCT/EP2010/059024 WO2010149752A2 (fr) | 2009-06-25 | 2010-06-24 | Nouvelles compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
MA33440B1 true MA33440B1 (fr) | 2012-07-03 |
Family
ID=43014491
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA34546A MA33440B1 (fr) | 2009-06-25 | 2010-06-24 | Nouvelles compositions |
Country Status (20)
Country | Link |
---|---|
US (1) | US20120087937A1 (fr) |
EP (1) | EP2445525A2 (fr) |
JP (1) | JP2012530505A (fr) |
KR (1) | KR20120098580A (fr) |
CN (1) | CN102497880A (fr) |
AU (1) | AU2010264695A1 (fr) |
BR (1) | BRPI1014718A2 (fr) |
CA (1) | CA2768172A1 (fr) |
CL (1) | CL2011003271A1 (fr) |
CO (1) | CO6480995A2 (fr) |
CR (1) | CR20120026A (fr) |
DO (1) | DOP2011000396A (fr) |
EA (1) | EA022213B1 (fr) |
IL (1) | IL217094A0 (fr) |
MA (1) | MA33440B1 (fr) |
MX (1) | MX2011013744A (fr) |
PE (1) | PE20120563A1 (fr) |
SG (1) | SG177269A1 (fr) |
WO (1) | WO2010149752A2 (fr) |
ZA (1) | ZA201109453B (fr) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK2416798T3 (en) * | 2009-04-10 | 2018-01-08 | Univ Johns Hopkins | PAPILLOMAVIRUS-LIKE PARTICLES (VLP) AS WIDE-SPECIFIED VACCINES AGAINST HUMAN PAPILLOMAVIRUS (HPV) |
MX355352B (es) | 2011-12-01 | 2018-04-17 | Univ Cape Town | Particulas quimericas de vph. |
EP2827891A1 (fr) | 2012-03-18 | 2015-01-28 | GlaxoSmithKline Biologicals S.A. | Procédé de vaccination contre le papillomavirus humain |
CN103864936B (zh) * | 2012-12-11 | 2018-01-23 | 中国疾病预防控制中心病毒病预防控制所 | Hpv18型l2ne7e6融合蛋白基因、表达载体、方法、菌株和用途 |
EP2940133A4 (fr) * | 2012-12-25 | 2016-07-06 | Chemo Sero Therapeut Res Inst | Vaccin contre l'infection par le hpv et/ou l'hépatite b contenant une protéine hpv/hbs chimérique à titre de principe actif |
CN111154777B (zh) * | 2014-02-18 | 2023-08-15 | 上海泽润生物科技有限公司 | 重组人***瘤病毒蛋白表达 |
CN104531741B (zh) * | 2014-08-22 | 2016-08-24 | 天津康希诺生物技术有限公司 | 增强hpv抗原表位肽免疫原性的方法及类病毒颗粒、颗粒制备方法与应用 |
WO2016065281A1 (fr) | 2014-10-24 | 2016-04-28 | Tim Ioannides | Traitement du cancer et de lésions cutanées |
US10799574B2 (en) | 2014-10-24 | 2020-10-13 | Hpvvax. Llc | Method and composition for treating cancer or skin lesion using a vaccine |
EP3368068B1 (fr) | 2015-10-30 | 2020-11-18 | University of Copenhagen | Pseudo-particule virale à présentation efficace des épitopes |
EP3385273A4 (fr) * | 2015-12-04 | 2019-08-07 | Xiamen University | Mutant de la protéine l1 du virus du papillome humain de type 58 |
CA3015519A1 (fr) * | 2016-02-27 | 2017-08-31 | Hpvvax, Llc | Methode et composition pour traiter le cancer ou une lesion cutanee a l'aide d'un vaccin |
CN107188966B (zh) | 2016-03-15 | 2020-03-31 | 中国医学科学院基础医学研究所 | 一种***瘤病毒嵌合蛋白及其用途 |
CN107188967B (zh) * | 2016-03-15 | 2020-03-31 | 中国医学科学院基础医学研究所 | 一种***瘤病毒嵌合蛋白及其用途 |
KR102567627B1 (ko) * | 2017-07-14 | 2023-08-17 | 시아먼 유니버시티 | 인간 유두종 바이러스 타입 16의 l1 단백질의 변이체 |
BR112021005626A2 (pt) * | 2018-09-26 | 2021-06-29 | Xiamen University | mutante de proteína l1 de papilomavírus humano de tipo 51 |
CN114127097A (zh) * | 2019-07-19 | 2022-03-01 | 神州细胞工程有限公司 | 嵌合的人***瘤病毒56型l1蛋白 |
CN114127094B (zh) * | 2019-07-19 | 2024-04-26 | 神州细胞工程有限公司 | 嵌合的人***瘤病毒58型l1蛋白 |
CN114127099B (zh) * | 2019-07-19 | 2024-04-19 | 神州细胞工程有限公司 | 嵌合的人***瘤病毒6型l1蛋白 |
CN111944834A (zh) * | 2020-09-04 | 2020-11-17 | 吉林医药学院 | 人***瘤病毒16型表位嵌合l1的重组载体、重组蛋白、病毒样颗粒及其制备和应用 |
CN112300290B (zh) * | 2020-09-30 | 2022-04-01 | 北京康乐卫士生物技术股份有限公司 | 一种使用***瘤病毒类病毒颗粒递呈抗原的新型冠状病毒多肽疫苗 |
CN114716562B (zh) * | 2021-01-04 | 2023-11-10 | 中国医学科学院基础医学研究所 | 一种人***瘤病毒58型嵌合蛋白及其用途 |
CN114716560B (zh) * | 2021-01-04 | 2024-02-02 | 中国医学科学院基础医学研究所 | 一种人***瘤病毒18型嵌合蛋白及其用途 |
CN114716561B (zh) * | 2021-01-04 | 2024-03-12 | 中国医学科学院基础医学研究所 | 一种人***瘤病毒31型嵌合蛋白及其用途 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL117459A (en) * | 1995-03-22 | 2005-11-20 | Merck & Co Inc | Dna encoding human papillomavirus type 18 |
US7351533B2 (en) | 1997-09-05 | 2008-04-01 | Medimmune, Inc. | In vitro method for disassmbly/reassembly of papillomavirus virus-like particles (VLPs). Homogeneous VLP and cavsomere compositions produced by said methods: use thereof as vehicle for improved purification, and delivery of active agents |
ATE333501T1 (de) | 1997-09-05 | 2006-08-15 | Medimmune Inc | Methode zur in vitro auseinander- und wiederzusammensetzung von papillomavirus virus- ähnlichen tielchen (vlps) |
WO1999014377A2 (fr) | 1997-09-16 | 1999-03-25 | Innogenetics N.V. | Detection et identification du virus du papillome humain au moyen d'une pcr et d'une hybridation inverse specifique de type |
EP2266604A3 (fr) | 1998-10-16 | 2011-05-11 | GlaxoSmithKline Biologicals S.A. | Produits adjuvants et vaccins |
GB9921146D0 (en) * | 1999-09-07 | 1999-11-10 | Smithkline Beecham Biolog | Novel composition |
JP2004538010A (ja) | 2001-08-08 | 2004-12-24 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | アッセイ |
GB0206360D0 (en) * | 2002-03-18 | 2002-05-01 | Glaxosmithkline Biolog Sa | Viral antigens |
JP4614765B2 (ja) * | 2002-05-17 | 2011-01-19 | ユニバーシティ・オブ・ケープ・タウン | L2ペプチドを含むキメラ・ヒト・パピローマウイルス16l1タンパク質、それから調製したウイルス様粒子および該粒子の調製方法 |
GB0228715D0 (en) | 2002-12-09 | 2003-01-15 | Glaxosmithkline Biolog Sa | Vaccine |
EP1853307B1 (fr) | 2005-02-01 | 2016-12-14 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, the Department of Health and Human Services, | Peptides de l'extrémité N-terminale de la protéine L2 de Papillomavirus permettant d'induire des anticorps à neutralisation croisée large |
JP4825958B2 (ja) * | 2005-08-10 | 2011-11-30 | 財団法人ヒューマンサイエンス振興財団 | 高リスク群ヒトパピローマウイルスの中和抗体を誘導する抗原 |
JP5540329B2 (ja) * | 2007-06-26 | 2014-07-02 | 公益財団法人ヒューマンサイエンス振興財団 | 高リスク群ヒトパピローマウイルスに対する交差性中和抗体を誘導するワクチン抗原 |
AU2008318320B2 (en) * | 2007-11-02 | 2014-11-27 | The Johns Hopkins University | Multitype HPV peptide compositions and methods for treatment or prevention of human papillomavirus infection |
MX2011001218A (es) | 2008-07-31 | 2011-03-15 | Glaxosmithkline Biolog Sa | Vacuna contra el virus de papiloma humano. |
-
2010
- 2010-06-24 CN CN2010800386242A patent/CN102497880A/zh active Pending
- 2010-06-24 PE PE2011002154A patent/PE20120563A1/es not_active Application Discontinuation
- 2010-06-24 US US13/378,446 patent/US20120087937A1/en not_active Abandoned
- 2010-06-24 EA EA201190327A patent/EA022213B1/ru not_active IP Right Cessation
- 2010-06-24 SG SG2011093572A patent/SG177269A1/en unknown
- 2010-06-24 WO PCT/EP2010/059024 patent/WO2010149752A2/fr active Application Filing
- 2010-06-24 MX MX2011013744A patent/MX2011013744A/es not_active Application Discontinuation
- 2010-06-24 JP JP2012516750A patent/JP2012530505A/ja active Pending
- 2010-06-24 CA CA2768172A patent/CA2768172A1/fr not_active Abandoned
- 2010-06-24 KR KR1020127001919A patent/KR20120098580A/ko not_active Application Discontinuation
- 2010-06-24 AU AU2010264695A patent/AU2010264695A1/en not_active Abandoned
- 2010-06-24 BR BRPI1014718A patent/BRPI1014718A2/pt not_active IP Right Cessation
- 2010-06-24 EP EP10727731A patent/EP2445525A2/fr not_active Withdrawn
- 2010-06-24 MA MA34546A patent/MA33440B1/fr unknown
-
2011
- 2011-12-19 DO DO2011000396A patent/DOP2011000396A/es unknown
- 2011-12-20 IL IL217094A patent/IL217094A0/en unknown
- 2011-12-21 ZA ZA2011/09453A patent/ZA201109453B/en unknown
- 2011-12-22 CL CL2011003271A patent/CL2011003271A1/es unknown
-
2012
- 2012-01-04 CO CO12001297A patent/CO6480995A2/es unknown
- 2012-01-16 CR CR20120026A patent/CR20120026A/es unknown
Also Published As
Publication number | Publication date |
---|---|
AU2010264695A1 (en) | 2012-01-19 |
EA201190327A1 (ru) | 2012-07-30 |
CA2768172A1 (fr) | 2010-12-29 |
MX2011013744A (es) | 2012-09-28 |
PE20120563A1 (es) | 2012-05-17 |
CO6480995A2 (es) | 2012-07-16 |
EP2445525A2 (fr) | 2012-05-02 |
US20120087937A1 (en) | 2012-04-12 |
WO2010149752A2 (fr) | 2010-12-29 |
DOP2011000396A (es) | 2012-02-15 |
CR20120026A (es) | 2012-04-13 |
WO2010149752A3 (fr) | 2011-03-31 |
EA022213B1 (ru) | 2015-11-30 |
SG177269A1 (en) | 2012-02-28 |
CL2011003271A1 (es) | 2012-08-31 |
CN102497880A (zh) | 2012-06-13 |
JP2012530505A (ja) | 2012-12-06 |
BRPI1014718A2 (pt) | 2016-04-12 |
ZA201109453B (en) | 2012-08-29 |
KR20120098580A (ko) | 2012-09-05 |
IL217094A0 (en) | 2012-02-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA33440B1 (fr) | Nouvelles compositions | |
SG169375A1 (en) | Yeast-based vaccine for inducing an immune response | |
MA35110B1 (fr) | Protéines de fusion et polyvaccins comprenant la protéine e et la piline a d'haemophilus influenzae | |
MA30581B1 (fr) | Vaccin viral recombinant | |
ATE527281T1 (de) | Impfstoffe gegen aids umfassend cmv/r nucleinsäurekonstrukte | |
MY129263A (en) | Vaccine composition | |
EP3266464A3 (fr) | Thérapeutique à base de levure pour infection chronique par l'hépatite b | |
WO2007011904A3 (fr) | Vaccins recombinants contre la grippe | |
WO2009026465A3 (fr) | Composition et procédés de fabrication et d'utilisation de protéines de la grippe | |
WO2007054279A3 (fr) | Dinucleotides cycliques et leurs conjugues utiles en tant qu'adjuvants et leurs utilisations dans des compositions pharmaceutiques | |
MXPA05009580A (es) | Vacuna contra el virus de la influenza. | |
WO2005116270A3 (fr) | Composition de vaccin contre le virus de la grippe et ses methodes d'utilisation | |
WO2007022425A3 (fr) | Vaccin a sous-unites recombinees du virus de la grippe | |
WO2008124646A3 (fr) | Utilisation de protéines amyloïdes en tant qu'échafaudages pour des vaccins | |
EA200802170A1 (ru) | Лиофилизированная композиция терапевтического пептидного антитела | |
TW200637910A (en) | Recombinant BCG strains with enhanced ability to escape the endosome | |
WO2008103380A3 (fr) | Compositions contre le virus de l'hépatite b, et procédés d'utilisation | |
WO2008036146A3 (fr) | Construction de vaccins antiviraux de recombinaison par insertion directe à médiation par transposon de déterminants immunologiques étrangers dans des protéines de virus vecteur | |
EA201390812A1 (ru) | Лиофилизированные вирусные составы | |
EA201591213A1 (ru) | Вакцины против вируса гепатита b | |
AU2003246373A8 (en) | Recombinant measles viruses expressing epitopes of antigens of rna viruses - use for the preparation of vaccine compositions | |
DE60330708D1 (de) | Impfstoff gegen das west-nile-virus | |
WO2008054535A3 (fr) | Nouveaux vaccins contre l'influenza m2 | |
ATE552847T1 (de) | Hiv-impfstoffzusammensetzung | |
EA200600403A1 (ru) | Препараты кладрибина для улучшенной пероральной доставки и доставки через слизистые оболочки |